6:11 PM
Jun 18, 2009
 |  BC Extra  |  Company News

NICE recommends Revlimid for MM

The U.K.'s NICE issued final guidance recommending the use of Revlimid lenalidomide from Celgene Corp. (NASDAQ:CELG) in combination with dexamethasone to...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >